Atlas Trials

Biweekly Docetaxel in Patients With Metastatic Breast Cancer.

Clinical trial NCT02041351 · COMPLETED

Trial details

NCT number
NCT02041351
Sponsor
Centro Universitario contra el Cáncer
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Metastatic Breast Cancer
Start date
2013-11-01
Primary completion
2014-01-01
Enrollment
17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.